Artiklar av Thomas Hedner

CRISPR/Cas9 system and gene editing tools – On patent rights, recent disputes and its potential commercial applicability in biotechnology and medicine

Publicerad i Stockholm IP Law Review 2019 #1, juni 2019 s. 12–23